Maximakare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 9.00 M
- Revenue Growth 206.89%
- Profit Growth -24.69%
- Ebitda 7.65%
- Net Worth -172.28%
- Total Assets 24.79%
About Maximakare Lifesciences
Maximakare Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2015 (Nine years and ten months 17 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹9.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Roop Rastogi and Ritu Srivastava serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2015PTC069907
-
Company No.
069907
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 2015
-
Date of AGM
30 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Maximakare Lifesciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roop Rastogi
|
Managing Director | 01-Apr-2015 | Current |
|
Ritu Srivastava
|
Managing Director | 16-Jan-2016 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Maximakare Lifesciences.
Maximakare Lifesciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 206.89% increase. The company also saw a substantial fall in profitability, with a 24.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 172.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maximakare Lifesciences?
In 2017, Maximakare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dermakare Pharmaceuticals Private LimitedRoop Rastogi is a mutual person
Charges (Loans)
₹0
₹9.00 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2016 | Canara Bank | ₹9.00 M | Satisfied |
How Many Employees Work at Maximakare Lifesciences?
Unlock and access historical data on people associated with Maximakare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maximakare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maximakare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
